Back to search

Article

Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma

2025-11-01

Abstract excerpt

<title>Abstract</title> <p> Adrenocortical cancer (ACC) is a rare and aggressive malignancy with poor survival due to a lack of effective treatments; therefore, it is important to identify therapies to be readily studied in clinical trials. Quantitative high-throughput drug combination screening identified potent synergy between phosphatidylinositol-3-kinase (PI3K) inhibitor, PIK75 and heat shock protein 90 (HSP...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bae7d904-e87d-5f71-ab3b-6f6fd1b7a918
DOI
10.21203/rs.3.rs-7761877/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical CarcinomaDOI 10.21203/rs.3.rs-7761877/v1
Select a neighboring publication to make it the new centre.